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Abstract
Genetic variations in toll-like receptors and cytokine genes of the innate immune pathways have been implicated in
controlling parasite growth and the pathogenesis of Plasmodium falciparum mediated malaria. We previously published
genetic association of TLR4 non-synonymous and TNF-a promoter polymorphisms with P.falciparum blood infection level
and here we extend the study considerably by (i) investigating genetic dependence of parasite-load on interleukin-12B
polymorphisms, (ii) reconstructing gene-gene interactions among candidate TLRs and cytokine loci, (iii) exploring genetic
and functional impact of epistatic models and (iv) providing mechanistic insights into functionality of disease-associated
regulatory polymorphisms. Our data revealed that carriage of AA (P = 0.0001) and AC (P = 0.01) genotypes of IL12B 39UTR
polymorphism was associated with a significant increase of mean log-parasitemia relative to rare homozygous genotype CC.
Presence of IL12B+1188 polymorphism in five of six multifactor models reinforced its strong genetic impact on malaria
phenotype. Elevation of genetic risk in two-component models compared to the corresponding single locus and reduction
of IL12B (2.2 fold) and lymphotoxin-a (1.7 fold) expressions in patients’peripheral-blood-mononuclear-cells under
TLR4Thr399Ile risk genotype background substantiated the role of Multifactor Dimensionality Reduction derived models.
Marked reduction of promoter activity of TNF-a risk haplotype (C-C-G-G) compared to wild-type haplotype (T-C-G-G) with
(84%) and without (78%) LPS stimulation and the loss of binding of transcription factors detected in-silico supported a
causal role of TNF-1031. Significantly lower expression of IL12B+1188 AA (5 fold) and AC (9 fold) genotypes compared to CC
and under-representation (P = 0.0048) of allele A in transcripts of patients’ PBMCs suggested an Allele-Expression-Imbalance.
Allele (A+1188C) dependent differential stability (2 fold) of IL12B-transcripts upon actinomycin-D treatment and observed
structural modulation (P = 0.013) of RNA-ensemble were the plausible explanations for AEI. In conclusion, our data provides
functional support to the hypothesis that de-regulated receptor-cytokine axis of innate immune pathway influences blood
infection level in P. falciparum malaria.
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Introduction
Infection with Plasmodium falciparum is still a major health
problem worldwide, causing about 225 million new malaria cases
each year [1]. Majority of the patients with parasite infection
present febrile symptoms while a subgroup develops life-threaten-
ing complications such as severe malarial anemia (SMA) or
cerebral malaria (CM). Malaria parasitemia which affects disease
severity and transmission is controlled by a balance between
depletion of red blood cells and immune clearance by T-helper
cells, B lymphocytes, and cytokines as shown in murine model of
Plasmodium chabaudi infection [2–4]. The role of innate immunity to
restrict parasite growth in rodent model is further demonstrated by
a recent study which shows when parasite dose saturates the
capacity of innate response; experimentally enhanced innate
immunity can control parasite density indirectly by depletion of
RBCs [5]. In humans, hemoglobin degradation and heme
detoxification by the obligate intracellular malaria parasite results
in the formation of hemozoin (HZ) which along with malarial
glycosylphosphatidylinositol (GPI) prime innate immune response
by the production of pro-inflammatory cytokines through toll-like
receptor mediated signaling [6,7]. Two important functions of
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innate immunity in the defense against the parasite are (i) it
triggers a battery of pro-inflammatory cytokines inhibiting rapid
parasite growth and thereby limiting the onset of malaria
pathology and (ii) it determines the type and efficiency of
subsequent parasite specific adaptive immune responses through
the cytokine mediators at later stages of infection [8–10]. An
account of the etiological components of innate immunity and the
mechanistic framework of their interactions will offer the much
needed therapeutic alternatives for control of the global burden of
malaria.
Genetic studies correlating malaria susceptibility with host
immunity have a long history. Majority of the studies on the role of
host genetics in determining malaria susceptibility have utilized
population based case-control design and candidate or genome
wide markers [11–20]. A general concern about the association
study is that the alliance between disease phenotype and genetic
loci remains tentative unless a functional causality is established.
The major objective of this study is to understand the interactions
and functional contribution of host genetic factors associated with
a measurable phenotype, namely parasitemia, to extract an
improved insight of host regulatory mechanisms controlling the
blood infection level in P. falciparum mediated malaria. We have
published a genetic association study of this phenotype analyzing
fourteen single nucleotide polymorphisms (SNPs) located on genes
encoding toll-like-receptor (TLR)-2, 4 and 9 and tumor necrosis
factor-a (TNF-a) and lymphotoxin-a (LTA) and reported signifi-
cant correlation of blood parasitemia with TLR4 non-synonymous
and TNF-a promoter polymorphisms in Indian patients with mild
malaria [21]. Here we extend this analysis by investigating genetic
association between polymorphic variability of IL12B, which
encodes the IL-12p40 subunit of IL12, with blood parasitemia.
IL12 is a heterodimeric pro-inflammatory cytokine with pleiotro-
pic effects, acting as a potent immune-regulatory molecule and
hematopoietic growth factor in infections caused by Plasmodium
parasites [22]. It is produced by phagocytes and dendritic cells in
response to pathogens through toll-like and other extracellular
receptors. Physiologically the most important target cells of IL12
are hematopoietic progenitors, NK cells and T cells for which it
induces proliferation and production of type-1 cytokines (e.g. IFN-
c). IL12 and IFN-c together enhance activation and production of
Th1 associated classes of immunoglobulin from B cells [23]. IL12 is
composed of a 35 kD subunit encoded by IL12A and 40 kD
subunit encoded by IL12B. Polymorphisms in genes encoding both
the subunits have been reported in a wide range of immune and
inflammatory diseases including malaria [24–34].
Given the complexity of parasite biology and host immune
system, it is unlikely that genetic variation of a single locus would
provide an adequate explanation of inter-individual differences of
host immune response which results in diverse clinical manifes-
tations. To this end, identification of gene-gene interactions could
enhance the power and accuracy of predicting disease outcome of
a complex disorder. We have collated the genetic data on IL12B
from the present report with that on toll-like receptors and
cytokine loci from our previous study [21] to model the possible
genetic interactions that may account for the differences in blood
parasitemia in malaria patients. The functional relevance of
receptor-cytokine epistatic models has been captured by analysis of
receptor-genotype dependence of cytokine expression in vivo.
For a better description of genetic architecture of disease
susceptibility and unambiguous identification of factors responsible
for both causality and predisposition to a disease, functional
appraisal of disease-associated polymorphisms is essential. There is
widespread recognition that differences in gene expression may be
an important source of phenotypic diversity in complex diseases
[35–37] and that non-coding polymorphisms contribute to the
variance and etiology of a trait by regulating the expression of
nearby genes [38,39]. To explore the plausible regulatory
mechanisms exerted by cytokine SNPs we have characterized
the allele specific events by studying their transcriptional
differences in terms of reporter gene activities and allelic-
expression-imbalance (AEI). Our study provides detailed insights
into molecular effects of cis-regulatory variants in controlling
cytokine gene expression in P. falciparum mediated malaria.
However it underscores the possibility that this complex trait
involves even more complex regulatory intricacies than previously
anticipated.
Materials and Methods
Patient recruitment and Laboratory measures
A total of 293 mild malaria patients (age = 16–37 years) with
Plasmodium falciparum infection were recruited from The Calcutta
School of Tropical Medicine between September 2008 and
January 2009 following WHO guidelines after obtaining the
written informed consent from each study participant [40].
Patients with bacteremia, measles, acute lower respiratory tract
infection, severe diarrhea with dehydration and other chronic or
severe diseases such as cardiac, renal or hepatic diseases, HIV/
AIDS were excluded from the study [21,40]. Appropriate
approvals have been obtained from Institutional ethical commit-
tees of University of Calcutta and The Calcutta School of Tropical
Medicine, India. Parasitemia status of each patient was deter-
mined during their first visit to the clinic using Giemsa-stained
blood smears and oil immersion microscopy. Detailed description
of study samples and procedure for parasite enumeration can be
found in our earlier report [21]. For genetic epidemiology, the
patient pool from our previous study was used while for functional
analyses case samples were enrolled (N= 64, age = 4–16 years) and
registered in the year 2010 during July to September, from
Calcutta National Medical College & Hospital, Kolkata, India as
per WHO 2006 guidelines [40]. The blood samples for genetic
and functional analyses were collected before any medical
interventions.
Genotyping IL12B polymorphisms
Genomic DNA was extracted from peripheral blood leukocytes
using a QIAamp DNA Blood Kit (Qiagen, Hilden, Germany).
IL12B promoter (rs17860508) and 39UTR (rs3212227) polymor-
phisms were assayed through PCR followed by an allele specific
restriction enzyme digestion. The primer pairs for genotyping
were listed in Table S1. PCR amplification was carried out in
10 ml reaction mixtures containing 1 U AmpliTaq GoldTM DNA
polymerase, 1.5 mM MgCl2, 250 mM of each dNTP, 5 pmoles of
each primer (Sigma Aldrich, St. Louis, MO). The cycling
parameters consisted of an initial denaturation at 96uC for 5 mins,
followed by 40 cycles of denaturation at 96uC for 30 sec,
annealing at 60uC for 30 sec, extension at 72uC for 30 sec, and
then completed with a final extension at 72uC for 5 mins using a
thermal cycler (Applied BiosystemsH GeneAmpH PCR System
9700). PCR amplicons were digested with AluI (rs17860508) and
TaqI (rs3212227) (Fermentas International Inc.) at 37uC and 65uC
respectively according to manufacturer’s protocol. Digestion
patterns were analyzed by electrophoresis in agarose gel. The
accuracy of the PCR-RFLP assay was confirmed for each locus by
randomly selecting 10% of total samples and sequencing the PCR
products on ABI Prism 3100 Genetic Analyzer using Big-Dye
Terminator v3.1 (Applied Biosystems, Foster City, CA).
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Statistical analysis. All the statistical tests were performed
using SPSS version 10.0 and R-program (version 2.0 package).
Associations between alleles/genotypes and parasite estimate were
considered ‘‘strong’’ and ‘‘statistically significant’’ in cases where
the P-value,0.05.
(a) Single Gene Analysis: Distribution of allele and
genotype frequencies and genetic risk assessment of
IL12B polymorphisms. The allele and genotype frequencies
for IL12B SNPs were estimated by gene counting and Hardy–
Weinberg equilibrium was evaluated by x2 test using Haploview
(http://www.broad.mit.edu/mpg/haploview/). Pairwise compar-
isons between log-transformed parasitemia and genotypic classes
for IL12Bpro and +1188 loci were analyzed by model based
independent t test and ANOVA F-ratio. The results were further
validated using non-parametric Wilcoxon Rank sum and Kruskal
Wallis H tests. Bonferroni correction was done for multiple testing.
For allele based risk assessment, the unprocessed parasitemia data
was previously dichotomized into high (N=88) and low (N= 205)
parasitemic groups employing the two component mixture model
and expectation-maximization algorithm and a threshold value of
7520 parasites/ml or 3.88 log-parasitemia was derived as the
cutoff. Detailed procedure of this strategy was described earlier
[21]. The proportion of the risk allele for each locus was compared
between high and low parasitemic groups using a two-way
contingency table.
(b) Multi-loci Analyses: Multifactor Dimensionality
Reduction analysis. We adopted the multifactor dimensional-
ity reduction (MDR) method upon merging the IL12B genotype
data with those from our previous genetic epidemiologic study for
identification of non-additive epistatic interactions [21,41–46].
MDR is a non-parametric approach which converts multiple
variables into a single attribute, thereby changing the represen-
tation space of the data. To run MDR, eight out of sixteen loci
from the assembled dataset were selected as they showed an
increasing/decreasing trend of log-parasitemia distribution across
three genotypes which allowed us to code the genotypes into
distinct risk groups. The ‘‘low’’, ‘‘moderate’’ and ‘‘high’’ risk
genotypic classes for each locus were designated as ‘‘0’’, ‘‘1’’ and
‘‘2’’ while the ‘‘low’’ and ‘‘high’’ parasitemic groups were assigned
as ‘‘0’’ and ‘‘1’’ respectively to depict the disease status. Since an
equal number of sample size in high and low risk groups was a
prerequisite for execution of MDR, the sample size of our analysis
was kept to eighty eight, the number that represented in the high
parasitemic group. Of the 205 individuals belonging to low
parasitemic group, 100 distinct files each comprising of 88
individuals were generated using random numbers as seeds using
R version 2.0 package to minimize the chance of detecting
spurious results due to any bias. This was run on MDR software to
obtain 100 independent outputs (version 2.0 beta 8.2). From eight
genetic attributes (SNPs) namely TLR4Thr399Ile (rs4986791),
IL12B+1188 (rs3212227), TNF-1031 (rs1799964), TNF-857
(rs1799724), TNF489 (rs1800610), LTA80 (rs2239704), LTA252
(rs909253), and TLR9P545P (rs352140), the possible multilocus
genotypes were represented in a multidimensional contingency
tables and classified as ‘‘high risk’’ if the ratio between two groups
exceeded a threshold tested over the entire training data set. After
reducing the dimensionality, all factor combinations were evalu-
ated for their ability to classify the disease status in the training
dataset and the best combination of factors with the minimum
prediction error (1-testing balance accuracy) was calculated from
the test dataset. Then the entire data was partitioned into 100
different subsets for cross-validation, from which ninety nine out of
100 subsets were assigned as a training balanced set (99/100) while
the remaining one hundredth dataset (1/100) was termed as
testing balanced set. To assign statistically meaningful gene-gene
combinations, 100 MDR files were permutated 10,000 times using
MDR permutation testing software (version 1.0 beta 2.0). The
models with P value,0.05 and .95% average cross-validation
consistency (CVC) were regarded as the best predictive models. To
infer the genetic risk of the multifactorial models, we used odds
ratio (OR) as a measure of association between genetic polymor-
phisms and blood infection intensity. The value of ORs was
logarithmically transformed and standard errors were derived
from the confidence intervals (CI). Genotype counts of the
constituent loci between high and low parasitemic groups were
used to calculate ORs and their corresponding 95% CIs for each
gene-gene interaction model. A forest plot (blobbogram) was used
to present the ORs and their 95% CIs estimated from the two-way
interaction models where the odds ratio was denoted by a dot and
the width of the horizontal line represented the 95% CI for the
estimated OR.
RNA extraction from PBMC fraction and cDNA synthesis
Peripheral blood mononuclear cells (PBMCs) were isolated from
fresh whole blood collected from malaria patients using Histopa-
que 1077 (Sigma Aldrich, St. Louis, MO) double-gradient density
centrifugation. Total RNA was extracted with TRIH Reagent
(Sigma Aldrich, St. Louis, MO) and dissolved in DEPC treated
water (Bioline). RNA (1 mg) samples were treated with 2 U of
RNAse free DNAse I (Fermentas Life Sciences, UK) and
incubated at 37uC for 30 mins to remove DNA contamination,
reverse transcribed using random hexamers and High Capacity
cDNA Reverse Transcription kit (Applied Biosystems Inc.). The
optimized condition for cDNA preparation was 10 mins at 25uC,
120 mins at 37uC followed by heating at 85uC for 5 mins in a
thermal cycler (Applied BiosystemsH GeneAmpH PCR System
9700) and stored at 220uC.
Quantitative Real Time PCR analyses
To scrutinize the genetic impact of TLR4 non-synonymous
polymorphism (rs4986791) on pro-inflammatory cytokine (IL12B
and LTA) production, we compared the expression of IL12B and
LTA genes under different TLR4Thr399Ile genotypic background.
Since TLR4Ile-Ile and TLR4 Thr-Ile genotypes together and
independently showed significantly low parasitemia compared to
that of TLR4Thr-Thr, we pooled individuals having genotypes Ile-
Ile with Thr-Ile genotypes and examined the pattern of cytokine
gene expression with respect to patients harboring TLR4Thr-Thr
genotype. The relative expression of IL12B was estimated for three
+1188 genotypes by qRT-PCR using 18S rRNA as an endogenous
control. The sequences of oligonucleotides used in the expression
analyses were listed in Table S1. A 1:10 fold dilution of cDNA
samples were used as the template and all qPCR reactions were
carried out in a 10 ml reaction volume with 5 ml of SYBR Green
Master Mix (Applied Biosystems) with optimized concentrations of
specific primers using Applied Biosystems 7900HT Fast Real-
Time PCR System. The thermal cycler was programmed for an
initial denaturation step of 5 min at 95uC and followed by 40
thermal cycles of 30 sec at 95uC, 30 sec at 60uC and 30 sec at
72uC. The experiments were carried out in triplicate including the
non template controls each time. Specificity of PCR amplification
for each primer pair was confirmed by melting curve analysis [47]
and the relative quantification (RQ) data was analyzed between
groups using the DDCt method. Statistical analysis on relative
expression levels was estimated using Mann–Whitney U-test (with
exact probabilities) for independent samples using SPSS (ver.
10.0., SPSS Inc. Chicago, IL).
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Allelic-Expression-Imbalance analysis
To examine the differential expression of IL12B 39UTR A and
C alleles, the peak heights of this transcribed SNP were compared
in patients heterozygous (AC) for IL12B+1188 polymorphism by
resequencing both genomic DNA (gDNA) and complementary
DNA (cDNA) counterpart. IL12Bexp primers (Table S1) were used
to amplify and resequence the 167 bp IL12B region encompassing
the polymorphic site. Sequencing was carried out on ABI Prism
3100 Genetic Analyzer using BigDye Terminator (BDT) v3.1
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) with
0.8 ml of the PCR product, and 5 pmoles of the primer in a 10 ml
reaction mixture. The raw sequence files (.ABI) were analyzed by
PeakPicker Software, originally developed and kindly provided by
Dr. T. Pastinen’s group [48]. Genomic DNA sequence from each
sample was selected as reference and the corresponding cDNA was
aligned with a default cutoff of 70%. The SNP was selected
manually and the peak heights of the alleles were estimated using
PeakPicker. The significant difference of IL12B+1188 A/C allele
ratio between the gDNA and cDNA was tested through a bivariate
Sign test in SPSS version 10.0.
Mapping of microRNA binding sites
To find out the potential microRNA binding sites within IL12B
mRNA, the entire IL12B 39UTR region was scanned using
miRNA-target prediction databases such as TargetScan (www.
targetscan.org/), miRBase (www.mirbase.org/), microRNA.org
(www.microrna.org/), RegRNA (www.regrna.mbc.nctu.edu.tw/),
MicroCosm (www.ebi.ac.uk/enright-srv/microcosm/). Target mi-
croRNAs were selected and compiled on the basis of its conserved
seed match or a seed match with a higher context score. The
thermodynamic stability of the mRNA-miRNA duplex was
calculated using RNAHybrid (www.bibiserv.techfak.uni-bielefeld.
de/rnahybrid/).
Construction of reporter fusion plasmids
(a) For TNF-a promoter assay. Five TNF-a promoter
haplotypes pertaining to four SNPs (TNF-1031, TNF-857, TNF-
308 and TNF-238) were selected for functional evaluation. The
1.2 kb fragment was amplified using TNFa_MluI_F.P and
TNFa_XhoI_R.P (Table S1) where MluI and XhoI recognition
sequences were appended into the primers for efficient cloning
into pGL3 vector. TNF-a haplotypes- T-C-G-G (Hap1), T-T-G-G
(Hap2) and C-C-G-G (Hap3) were directly cloned into TA vector
pTZ57R/T (InsTAcloneTM PCR Cloning Kit, Fermentas) using
the above primers by amplifying gDNA from patients harboring
the homozygous genotypes for all four loci. Haplotypes: T-C-A-G
(Hap4) and T-C-G-A (Hap5) were cloned by amplifying gDNA
from patients harboring genotypes T/T-C/C-G/A-G/G and T/
T-C/C-G/G-G/A respectively, followed by screening the clones
with restriction endonucleases NcoI for TNF-308 locus and
BamHI (NEB Inc., Bethesda) for TNF-238 respectively. DNA
amplification protocol was conditioned with an initial denatur-
ation at 95uC for 5 min, followed by 35 cycles of denaturation at
95uC for 1 min, annealing at 60uC for 1 min, extension at 72uC
for 1 min and a final extension of 15 min at 72uC in a thermal
cycler (Applied BiosystemsH GeneAmpH PCR System 9700). The
unique haplotypes from the TA constructs were subsequently
double-digested, purified using QIAquick Gel Extraction Kit
(Qiagen, Hilden, Germany) and subcloned in the upstream of
pGL3-Basic vector (kindly gifted by Dr. Susanta Roychowdhury).
The integrity of each polymorphic locus and directionality of all
the resulting constructs were confirmed by sequencing using both
vector and insert specific internal primers. Next, the reporter gene
expressions were measured in three different cell lines under the
presence and absence of endotoxin lipopolysaccharide (LPS)
stimulation using Luciferase Reporter Assay System (Promega,
Madison, WI).
(b) For IL12B39UTR assay. IL12B 39UTR sequence
(1047 bp) encompassing the A+1188C polymorphic site was
amplified using gene specific primers (Table S1). XhoI and NotI
(Fermentas International Inc.) restriction endonuclease recognition
sites were incorporated in the oligos for directional cloning. Allele
specific IL12B 39UTR containing the target sites for the
microRNAs was cloned into pTZ57R/T vector (InsTAcloneTM
PCR Cloning Kit, Fermentas) followed by subcloning into
pSiCHECK2 dual luciferase reporter plasmid (kindly gifted by
Dr. Soma Banerjee) in frame to the 39 end of the cDNA encoding
Renilla reniformis luciferase to produce pSiCHECK2-IL12B+1188A
and pSiCHECK2-IL12+1188C constructs. Approximately 100 bp
upstream and downstream sequences flanking the 70 nucleotide
pre-miR sequences (www.genecards.org/) were amplified for hsa-
miR-545, hsa-miR-1284, hsa-miR-23a and hsa-miR-23b using
appropriate primers (Table S1) and cloned into pRNAU6.1 vector
(kindly gifted by Dr. Soma Banerjee). The amplicons were inserted
into pRNAU6.1 vector by double digestion with BamHI and
HindIII (New England Biolabs, UK Ltd.). The orientation of the
recombinant vectors was checked by sequencing. Allele specific
transcript stability and miRNA-mediated IL12B 39UTR expres-
sion were examined with SYBR Green based qRT-PCR analysis
and by Dual-Luciferase Reporter (DLR) Assay System (Promega,
Madison, WI) respectively.
Cell culture, Transient transfection, Luciferase and mRNA
stability assay
HepG2 (hepatocellular adenocarcinoma), HEK293 (human
embryonic kidney), HCT116 (colon carcinoma) and U937 (human
leukemic monocyte lymphoma) cells were obtained from National
Centre for Cell Science, Pune, India and maintained in DMEM
medium containing 10% (v/v) fetal calf serum (Gibco BRL, Life
Technologies, Grand Island, USA), 100 units/ml penicillin,
100 mg/ml streptomycin in a humidified 5% CO2 atmosphere.
U937 cells were cultured in RPMI 1640 supplemented with 5 mM
glutamine and 10% (v/v) heat-inactivated fetal calf serum (Gibco
BRL, Life Technologies, Grand Island, USA) at 37uC in 5% CO2
atmosphere. Cells were seeded 14–16 hrs before transfection.
(a) TNF-a promoter haplotype assay. HepG2 cells
(1.06105) were plated in 12-well plates with DMEM/10% FCS
medium and were transiently transfected with 0.2 mg/ml of each
of the TNF-a promoter constructs (Hap1–Hap5) or empty pGL3-
Basic vector cotransfected with 0.5 mg/ml pSV-b-galactosidase
vector (Promega, Madison,WI) using Lipofectamine 2000 Reagent
(Invitrogen, Life Technologies, Carlsbad, USA) according to the
manufacturer’s protocol. pGL3-Basic vector (Promega, Madison,
USA) was used as control for luciferase assay and b-galactosidase
vector (Promega, Madison, USA) was used as transfection control.
To determine the optimum concentration of LPS (Sigma Aldrich,
St. Louis, MO) for stimulation assay, a dose response experiment
was performed with cells transiently transfected with TNF-Hap1
(T-C-G-G) followed by a stimulation of LPS solutions with five
different concentrations such as 250 ng/ml, 500 ng/ml, 1 mg/ml,
1.5 mg/ml to 2 mg/ml and luciferase activities were measured.
0.2 mg of each of the five reporter plasmids (Hap1–Hap5) were
transiently transfected. Thirty six hours post transfection, cells
were stimulated with optimized dose of LPS for 4–6 hr and
cellular extracts were prepared according to the manufacturer’s
instructions. Luminescence was measured as relative light units
(RLU) in GloMax 20/20 Luminometer (Promega, Madison, USA)
using 15 ml of cell supernatant. To normalize the luciferase
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activity, total protein concentration in each lysate was measured
by the standard Bradford (BioRad) method. Transfection normal-
ization was performed by b-galactosidase assay colorimetrically at
420 nm using O-nitrophenyl-b-D-galactopyranoside (ONPG) as
substrate (Promega, Madison, WI) in JASCO V-630 spectropho-
tometer. Measurements of mean 6 S.D were taken in triplicate.
Fold change represents the difference in promoter activity for
variant TNF-a haplotypes in comparison to the wild-type
promoter (Hap1). All the assays were done in triplicates and
repeated at least for three times. Similar experiments were also
performed in HEK293 and HCT116 cell lines both under LPS
stimulated and unstimulated conditions.
(b) IL12B mRNA stability assay by actinomycin-
D. Actinomycin-D (2-amino-N,N9-bis[(6S,9R,10S,13R,18aS)-
6,13-diisopropyl-2,5,9-trimethyl- 1,4,7,11,14-pentaoxohexadeca-
hydro-1H-pyrrolo[2,1-i] [1,4,7,10,13] oxatetraazacyclohexadecin-
10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide), a
polypeptide containing antibiotic, can inhibit transcription by
binding tightly and specifically to double-helical DNA [49,50]. It
has been extensively used as a highly specific inhibitor for the
formation of new de novo mRNA synthesis in both prokaryotic and
eukaryotic cells [51,52]. In this experiment, HepG2 cells were
transiently transfected with plasmid DNA containing the IL12B
39UTR fused to pSiCHECK2 vector, as described above. To
determine the optimal concentration of actinomycin-D (SRL,
Mumbai, India) in our experimental system, a range of
concentrations of actinomycin-D (0.1–10 mg/ml) were studied.
Twenty-four hours post-transfection with wild-type +1188AUTR
construct, actinomycin-D was added into the media and the cells
were harvested at different time points, i.e., 0, 1, 2, 4, 6, 18 and
24 hrs. Total RNA was extracted from these cells using TRIzolH
Reagent (Invitrogen Life Technologies) and IL12B mRNA level
was determined by RT-PCR and normalized with GAPDH and
18S rRNA genes. RNA isolated when actinomycin-D was just
added was denoted as the 0-hr time point and served as negative
control. It was compared with samples obtained at different time
points following actinomycin-D addition to select the adequate
incubation time where maximum change in expression could be
found for both alleles. To compare relative mRNA stability of
IL12B 39UTR A and C containing constructs, HepG2 cells were
transfected and de novo transcription was inhibited with the optimal
concentration of actinomycin-D. Cells were collected after 24 hrs
of actinomycin-D treatment and the mRNA levels of the
transfected gene (IL12B-39UTR/Luc) were determined by quan-
titative real-time PCR.
(c) IL12B 39UTR-microRNA interaction assay. HepG2
cells (16105) were transiently transfected with 0.1 mg/ml of the
IL12B+1188 wild type (A) and variant allele (C) containing
pSiCHECK2 dual reporter constructs alone and cotransfected
with either 0.2 mg/ml of empty miR-vector (pRNAU6.1) and/or
with the pre-miRNA (hsa-miR-545, hsa-miR-1284, hsa-miR-23a
and hsa-miR-23b) cloned in pRNAU6.1. Forty eight hours later,
cells were lysed; Firefly and Renilla luciferase activities were
evaluated using dual luciferase reporter assay system (Promega,
Madison, WI) in a GloMax 20/20 Luminometer. Renilla lucifer-
ase activity was normalized with respect to Firefly luciferase
activity and total protein produced was estimated by Bradford
method. All the transfection assays were done in triplicate and
repeated thrice. Measurements of mean 6 S.D were taken in
triplicate. The pairwise comparisons between each mRNA-
miRNA interactions were tested using Student-t test in GraphPad
Prism (http://www.graphpad.com).
Bioinformatic analysis: SNP based DNA and RNA
structural rearrangements
(a) TNF-1031 polymorphism associated DNA two
dimensional configurations. DNA folding was performed
with MFOLD version 3.0 (www.bioinfo.math.rpi.edu/,mfold/
dna/) using the DNA energy rules in structure-melting simula-
tions, with default parameters [53,54], i.e., having 1 M Na+
concentration (and 0.0 M Mg2+) at 37uC. Outputs were generated
in the form of structure plots based on minimum free energy
(MFE) calculations, single strand (ss) frequency count and energy
dot plots [55]. In addition, to identify the transcription factor
binding sites (TFBS) in the genomic sequence; TFBind (http://
tfbind.hgc.jp/) [56] was used to scan the 101 bp long sequence
flanking the promoter SNP (rs1799964) located at 51st position.
This positional pattern detection tool is able to attain high
sensitivity and specificity of detection by capturing the dependen-
cies between nucleotide positions within the TFBS.
(b) IL12B+1188 derived RNA structural ensemble
prediction. In an attempt to improve our understanding of
the structure and function relationship of the IL12B 39UTR
polymorphism on RNA turnover and stability, we performed an in
silico structural analysis including the wild type and variant form of
the locus on IL12B mRNA. An mRNA is unlikely to adopt a single
and stable conformation, but it exists in a population of structures
[57]; therefore instead of evaluating the minimum free energy
(MFE) values of biological sequences, those of randomized
sequences are now taken into account. As RNA secondary
structure might affect the functionality of component regulatory
elements, RNAfold program (http://rna.tbi.univie.ac.at/cgi-bin/
RNAfold.cgi) was employed to predict secondary structures under
default parameters and the folding temperature was fixed at 37uC
[55,58,59]. In addition to the minimum free energy approach
using RNA MFOLD and RNAfold, we adopted a partition
function calculation method which evaluates the entire ensemble
of possible RNA conformations for a given sequence and
computes the effect of single nucleotide polymorphisms on RNA
structural ensemble using SNPfold (http://ribosnitch.bio.unc.edu/
snpfold/SNPfold.html). The structures were also generated with
Sfold (http://sfold.wadsworth.org/) algorithm that computes
equilibrium partition functions for all substrings of an RNA
sequence based on the Turner thermodynamic parameters
[60,61]. Base-pair distances were used [62,63] as the basis for
evaluating dissimilarity between structures where the ‘‘centroid’’ in
the entire structure ensemble space has the shortest total base-pair
distance [62].
Results
The patients participating in this genetic association study were
recruited according to WHO 2006 guidelines [40]. All of them
displayed mild febrile symptoms, the summary of demographic,
clinical and laboratory characteristics of the study participants
were presented earlier [21]. In short, the crude parasitemia data
derived from thick and thin blood smears deviated from normal
behavior (skewness = 3.671), it was processed with log-transforma-
tion (skewness = 0.433) and regressed with respect to the covariate,
age (P value of correlation between age and parasite load was
0.074). For allele based genetic analyses, cases were stratified into
high and low parasitemic groups on the basis of a statistically
derived threshold value of 7520 or 3.88 in terms of crude and log-
parasite counts per ml respectively. The above threshold value was
obtained employing a two component mixture model and
Expectation Maximization algorithm [21]. No significant differ-
ences were observed in the distribution of age (P= 0.2632), gender
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(P = 0.3728), Hemoglobin count (P = 0.2971) and in average body
weight (P = 0.3901) between the high and low parasitemic groups.
Only peripheral parasitemia was found to be significantly different
(high= 15227611014; low= 271561705, P,0.0001) between the
groups.
Genetic analysis with IL12B polymorphisms
We studied the genetic variants located in the promoter and
39UTR region of the gene encoding IL12B by PCR based RFLP
method. Two biallelic markers; rs17860508 (designated as
IL12Bpro): a complex promoter insertion/deletion polymorphism
-/G/GC/TTAGA/TTAGAG situated at 22703 bp upstream of
the transcription initiation site and rs3212227 (designated as
IL12B+1188): an A to C substitution in the 39UTR region at
+1188 position of IL12B gene were selected to examine their
probable association with the blood infection intensity in two
hundred and ninety three patients exhibiting Plasmodium falciparum
mild malaria from Eastern India.
Genetic association between IL12B SNPs and peripheral
parasite load: Genotype & allelic
IL12Bpro (MAF: 0.35760.002) and IL12B+1188 (MAF:
0.40460.002) were found to be highly polymorphic in the study
population and there was no deviation from Hardy-Weinberg
equilibrium (P values = 0.3934 and 0.6799 for IL12Bpro and
IL12B+1188 respectively). The distribution of genotypes for
IL12Bpro and IL12B+1188 loci were summarized in Table 1.
For model dependent association analysis, the crude parasitemia
data collected from malaria patients was log transformed and
subjected to linear regression with respect to age in order to obtain
the standardized residuals which were then used to examine the
influence of genotypes at each locus on the parasite load under
Figure 1. Association between IL12B+1188 genotypes with blood infection level and IL12B gene-expression represented in Box plots.
(A) Diagram represented the distribution of log-parasitemia across three genotypes: 11 (AA), 12 (AC) & 22 (CC) and (B) Diagram represented the
comparison of log-parasitemia of minor homozygous genotype (CC) with AA and AC genotypic groups pooled. Statistical significance between
pairwise comparisons was mentioned. (C) The DCt distribution of IL12B gene expression across AA (N=24), AC (N= 28) and CC (N= 12) genotypes and
(D) comparison of gene expression between IL12B+1188CC genotype and with that of AA and AC individuals pooled together determined by
quantitative real time PCR. Statistical significance was determined by the Mann Whitney U test. P values and fold changes obtained for each pairwise
combination were appended in each plot. (*) indicates these differences to be statistically significant. The bottom, middle line, and top of each box
correspond to the 25th percentile, median, and the 75th percentile, respectively. Bars extend to the lowest value and to the highest value of each
group.
doi:10.1371/journal.pone.0046441.g001
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different genetic models. To find out the genetic risk conferred by
a SNP, IL12Bpro and IL12B+1188 were independently evaluated
as covariate using three genetic models viz., dominant ((11+12) vs
22), recessive (11 vs (12+22)), and additive (11 vs 12 vs 22), where 1
represents as the risk allele using independent t-test and ANOVA
(SPSS v10.0). The results of parametric analyses were substanti-
ated by Wilcoxon Rank Sum and Kruskal Wallis H tests for two
and three way comparisons respectively using the crude parasit-
emia data. Box-plot diagrams (Figure 1A & B) displayed a gradual
decline in parasitemia across three genotypes of IL12B+1188 locus
in which AA (11), AC (12) and CC (22) had the highest,
intermediate and lowest median values respectively. Significant
differences were obtained for the comparison 11 vs 12 vs 22 using
ANOVA test (P value = 0.001) and for the following pairwise
genotype comparisons namely (11+12) vs 22 (P value = 0.001); 12
vs 22 (P value = 0.014) and 11 vs 22 (P value = 0.0001) using
independent t-test presented in Table 1. The P values in the
parentheses were obtained after Bonferroni correction. Non-
parametric statistical tests yielded similar trends in the results
(Table 1). The mean log parasitemia of 11 (AA=3.6860.45)
genotype and the heterozygote genotype (AC=3.5860.41),
separately and jointly, differed significantly (P value = 0.001) from
that of 22 (CC=3.4060.35), while the difference between mean
parasite loads representing genotypes 11 and 12 was not
statistically significant (P value = 0.153) suggesting a dominant
effect of 1 (A) allele over allele 2 (C) for the IL12B+1188 locus to be
the most likely explanation. Similar statistical tests were conducted
on IL12Bpro (rs17860508), however none of the comparisons were
significant for this polymorphism. The linkage disequilibrium
estimate (r2) between these two loci that were 17,249 bp apart was
0.06 (P= 0.3052) suggesting an independent segregation of the
promoter and UTR polymorphisms in our population.
The allele based risk assessment for IL12B+1188 was performed
by stratifying the patients into ‘‘low’’ (N= 205) and ‘‘high’’
(N= 88) parasitemic groups. A detail of this procedure was
described elsewhere [21]. The proportions of two alleles A and C
of IL12B+1188 compared using a two way contingency table were
significantly different between the groups (P,0.001). The odds
ratio (OR) of comparison (1.887, 95% CI= 1.3–2.78) was due to
an excess of allele A in the ‘‘high’’ parasitemic group (Table 2).
Taken together, the results of the genetic association study
supported a strong influence of IL12B+1188 polymorphism on
P. falciparum infection load in our samples at both genotype and
allelic levels.
Evaluation of gene-gene interactions: Multilocus analyses
and MDR
The genetic etiology of complex diseases is considered to involve
interactions among multiple genetic variants and environmental
conditions. Multifactorial Dimensionality Reduction [41] was
performed to explore potential gene-gene interactions by combin-
ing the IL12B genotype data of this study with our previous one
[21]. We identified five two-factors (Model I–V) and one three-
factor (Model VI) gene-gene interaction models with an average
cross-validation consistency (CVC) .95% and a P value,0.05
using MDR permutation testing program. The gene-gene partners
of MDR models were summarized in Table 3. The interacting
models that satisfied the above criteria, included TLR4Thr399Ile
(rs4986391) and/or IL12B+1188 (rs3212227) in combination with
either TNF-1031 (rs1799964) or LTA80 (rs2239704) or
TLR9P545P (rs352140). The average prediction errors (PE) for
these models ranged from 0.305 to 0.366. To estimate the genetic
risk under a two-factor model, the proportions of individuals
harboring risk genotypes for partner loci, were compared between
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the low and high parasitemic groups. Since IL12B+1188 was
present in five out of six genetic models the odds ratio of the
second locus was estimated under IL12B+1188 risk (AA+AC)
background. The comparison of odds ratio (OR) and 95%
confidence intervals (CI) of two-way and the constituent interact-
ing partners were shown in the Forest plot (Figure 2A). The
proportion of risk genotypes of three SNPs, namely TLR4Thr399Ile
(Model I: OR=2.024, 95% CI 1.07–3.83, P value = 0.028), TNF-
1031 (Model III: OR=4.158, 95% CI 1.01–17.1, P value = 0.033)
and LTA80 (Model V: OR=2.22, 95% CI 1.04–4.73, P
value = 0.034) in association with IL12B+1188 elevated remark-
ably in high parasitemic groups compared to the single SNP
analyses (Figure 2A; ID: G, I and H). For Model II, odds ratio for
LTA80 (OR=2.113, 95% CI 1.0–4.44, P value = 0.047) under
TLR4 risk background (Thr-Thr) was also increased (Figure 2A;
ID: J). Notably, the difference in mean parasitemia for LTA80
between the genotype comparison (11+12) vs 22 was not
significant (OR=1.232, 95% CI 0.861–1.766, P value = 0.074)
when the locus was analyzed alone (Figure 2A; ID: A). In short,
except for TLR9P545P, all two-way epistatic models yielded higher
risk of developing high parasitemia compared to the single marker
analyses. Model VI: TLR4Thr399Ile/IL12B+1188/LTA80 did not
modify the risk significantly due to reduction of sample size in the
high parasite group when three loci were pooled.
TLR4 encodes an extra-cellular receptor present in the antigen
presenting cells (APCs) and perceives the malaria antigens to
trigger a complex cascade of downstream signaling events which
ultimately culminates into the production of several pro-inflam-
matory cytokines including IL12 and LTA [64,65]. To translate
functional impact of the above MDR derived gene-gene interac-
tion models (Model I and II) in terms of TLR4 mediated signaling
efficacy, we compared the expression levels of IL12B and LTA
genes under TLR4Thr399Ile risk (11; N= 16) and non-risk (12+22;
N= 33) genotype backgrounds using quantitative RT-PCR
analyses. Patients harboring heterozygous and the rare homozy-
gous genotypes (Thr-Ile and Ile-Ile) showed significantly increased
(2.2 fold, Mann Whitney P value = 0.001) expression of IL12B
gene (median DCt6S.D= 18.8060.87) compared to those with
homozygous (Thr-Thr) genotype (median DCt6S.D= 19.6360.74)
as shown in Figure 2B. The difference in LTA expression between
TLR4Thr399Ile risk and non-risk genotypic backgrounds did not
cross the threshold of statistical significance by non-parametric
Mann Whitney U test (1.7 fold, P value = 0.097), though the
expression of LTA gene (Figure 2C) was higher in TLR4Thr-Ile
and Ile-Ile genotype background (median DCt6S.D= 17.6661.7)
compared to that estimated in TLR4Thr-Thr risk environment
(median DCt6S.D=18.4361.5). Taken together, our results
provided the genetic (Figure 2A) and functional (Figure 2B & C)
validations of MDR gene-gene interaction models.
Functional analysis: TNF-a promoter and IL12B 39UTR
polymorphisms
In addition to provide functional support to the statistically
inferred epistatic models, we attempted to delineate the molecular
role of TNF-a promoter and IL12B 39UTR polymorphisms using a
combination of methods including quantitative RT-PCR, allelic-
expression-imbalance, mRNA stability assay, luciferase based
promoter (TNF-1031) and 39UTR (IL12B+1188) activity analyses,
bioinformatic prediction of putative mRNA-miRNA binding
interactions and SNP based DNA, RNA secondary structure
assessment.
(a) Efficiency of TNF-a promoter haplotypes under LPS
stimulated and unstimulated conditions: Reporter gene
assay and Bioinformatic support. To explore whether TNF-
1031 polymorphism influenced the basal rate of transcription of
the TNF-a gene, haplotypes pertaining to a 1.2 kb fragment
spanning the proximal promoter SNPs at positions 21031, 2857,
2308 and 2238 were subjected to reporter gene based assay.
Notably, haplotypes were derived using Haploview and out of the
16 possible haplotypes, only six were observed in our population
with haplotype T-C-G-G (1-1-1-1) showing the highest frequency
in both high and low parasitemic groups. This reference haplotype
as well as four other haplotypes that differed from the former at a
single nucleotide position were cloned. The frequency of the
variant haplotypes were .3% in the patient samples. Figure 3A
showed the map of the promoter haplotypes cloned and assayed
for reporter gene activity in HepG2 cells both in presence and
absence of LPS, which was known to be one of the parasite-
associated-molecular-patterns (PAMPs) recognized by TLR mole-
cules [66]. Fold changes in variant promoter (Hap2-5) activities
with respect to reference haplotype Hap1 were indicated in
Figure 3B. All four variant haplotypes (Hap2-5) showed decrease
in luciferase activity both in presence (250 ng/ml) of LPS (27–
84%) and in absence (12–78%) of the antigen (Figure 3B). The
maximum reduction in luciferase activity [78% (2LPS) and 84%
(+LPS), P,0.001] was observed for Hap3 construct (C-C-G-G)
which harbored the risk allele C for TNF-1031, the locus that
showed significant genotypic and allelic association with blood
parasite infection [21]. Our comparative promoter assay identified
Hap1 and Hap3 as the strongest and weakest promoter among the
five different TNF-a haplotypes in HepG2 cell line in three
independent experiments. Similar experiments were performed in
HEK293 and HCT116 in triplicate to compare the promoter
activities of Hap1 and Hap3 (Figure 3C). A consistent reduction of
the reporter gene expression under stimulated and unstimulated
conditions (80%) for Hap3 was noted in both the cell lines. The
control pGL3-Basic vector showed very low levels of relative
luciferase activity in both the unstimulated and LPS-stimulated
cells.
Table 2. Allele based risk assessment in patients with high and low parasite load.
Locus ID Allele
High Parasitemic group (N=88)
Frequency
Low Parasitemic group
(N=205) Frequency ORb (95% cCI) x2 (P-value)
IL12Bpro 1 0.68 0.63 1.28(0.88–1.85) 1.39 (0.238)
IL12B+1188 1 0.70 0.55 1.89(1.30–2.78) (0.001*)
Risk allele was boldfaced. N = total number of sample. x2-test was used to estimate the differences between the allele frequencies.
bOR= odds ratio.
cCI = confidence interval.
*P-Value,0.05.
doi:10.1371/journal.pone.0046441.t002
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Figure 2. Genetic and functional association of multifactor models obtained by Multifactorial Dimensionality Reduction analysis.
(A) Forest plots presented the comparison of risk estimates in terms of odds ratio (OR) and 95% confidence interval (CI) for significant gene-gene
interaction models and component single loci. The risk corresponding to each single and two factor models was denoted by a dot and the horizontal
lines represented odds ratio and 95% CI respectively. The model IDs (A–J) and respective ORs (95% CI) were given at the left and right side of each
dot in the forest plot. (B) IL12B and (C) LTA gene expression in patients’ PBMCs classified according to TLR4Thr399Ile genotype status by real time
quantitative PCR. Distribution of DCt was plotted and compared between the genotypic groups. Statistical significance was determined by Mann
Whitney U test. P values and corresponding fold changes obtained for each pairwise comparison were shown in the box plots. (*) indicates these
differences to be statistically significant.
doi:10.1371/journal.pone.0046441.g002
Table 3. Best predictive gene-gene interaction models identified by multifactor dimensionality reduction analysis.
Model No. Best Predictive Interaction Modela
Prediction Error
(1-TBAb)
10,000 Permutations
P-value c CVC (in %)
I TLR4Thr399Ile/IL12B+1188 0.318 0.024* 95
II TLR4Thr399Ile/LTA80 0.358 0.033* 100
III IL12B+1188/TNF-1031 0.341 0.013* 100
IV IL12B+1188/TLR9P545P 0.329 0.005* 100
V IL12B+1188/LTA80 0.366 0.042* 100
VI TLR4Thr399Ile/IL12B+1188/LTA80 0.305 0.031* 100
aThe best model was selected as the one with the minimum prediction error and maximum CVC.
bTBA corresponds to the testing balanced accuracy defined as the prediction error (PE) = 1-TBA.
cCVC corresponds to cross validation consistency.
*P values for gene-gene interaction models were calculated after 10,000 permutations in MDRpt software.
doi:10.1371/journal.pone.0046441.t003
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Scanning of a 101 bp region flanking 50 bp in the either
direction of TNF-1031 locus by TFBind program revealed that T
to C transition caused loss of binding of several transcription
factors. A list of the transcription factors that putatively showed
higher binding affinity for the T allele given by binding scores,
corresponding consensus and signal sequences with relative
nucleotide positions upstream of TNF-a coding sequence were
presented in Figure 3D. The possibility of altered DNA-protein
interactions in terms of changes in local secondary structure due to
the sequence variation at 21031 was examined using MFOLD
web server (Figure 3E and F). Out of the seventeen possible
computed foldings, thirteen (76.5%) with T at 21031 position
were found to be base paired while twenty (83.3%) out of twenty
four possible conformations had variant C allele locked in stems.
The minimum free energy (MFE) conformations constructed using
50 bp local DNA sequence encompassing TNF-1031 were shown
for wild type and variant alleles (Figure 3E & F). Results of these
in-silico comparisons indicated a relative reduction of accessibility
of a transcription factor when the risk allele was present in the
sequence. Taken together, the polymorphism at 21031 of TNF-a
caused a loss of promoter activity as well as transcription factor
binding as per our reporter gene assay and bioinformatics analyses
respectively.
(b) Impact of IL12B+1188 (rs3212227) genotypes and
alleles on gene expression: a quantitative
evaluation. IL12B+1188 polymorphism showed strong genetic
association with the blood parasite level in the malaria patients
both at genotype and allele levels. To test the hypothesis that this
Figure 3. Results of TNF-a promoter assay. (A) Schematic representation of reporter gene constructs for five TNF-a promoter haplotypes (Hap1–
Hap5) used for transfection assays. (B) HepG2 cells (16105 cells/ml) were transiently transfected with all promoter constructs and relative luciferase
activities in supernatants were measured alone (light grey) or with cells stimulated with 250 ng/ml of LPS (dark grey) after 48 hours. Activity of wild-
type promoter haplotype TNF-a-Hap1 served as reference and set at one, and the variant constructs were expressed as fold changes in relation to
this. Statistical significance for all pairwise comparisons was done by t-test. P values of significant differences between haplotype expressions were
marked with asterisks (*). (C) Similar experiments were performed with wild-type Hap1 and variant Hap3 constructs in HEK293 and HCT116 cells and
corresponding differences in promoter activities were measured. (*) indicates the significant comparisons given as P values. (D) Putative transcription
factor binding profiles for TNF-1031 T allele summarizing the TFs with their binding scores, consensus and signal sequences which were completely
abolished in presence of the variant (C) allele. (E & F) MFOLD derived representative DNA secondary structures encompassing 50 bp TNF-a promoter
sequence. The numbers indicate the base position while the arrowhead marks the 21031 site.
doi:10.1371/journal.pone.0046441.g003
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39UTR polymorphism may modulate IL12B transcript turnover,
relative expression of IL12B-mRNA was quantified using the
cDNA synthesized from mRNA extracted from peripheral blood
mononuclear cell (PBMC) fraction of whole blood collected from
individuals harboring three different genotypes namely AA
(N=24), AC (N=28) and CC (N=12) using real-time quantitative
PCR. Expression of IL12B was normalized for each individual
separately using 18S rRNA as an endogenous control. The median
and distribution of IL12B relative expression in terms of DCt for
IL12B+1188 AA, AC and CC genotypes was presented in
Figure 1C. No significant difference (P value = 0.165) in transcript
levels of IL12B gene was observed between genotype groups
representing AA (median DCt6S.D= 17.9861.40) and AC (
median
DCt6S.D=18.7461.67). On the other hand, the median level of
IL12B expression of AA (5 fold; P value = 0.005) and AC (9 fold; P
value = 0.0001) genotypic categories were significantly lower both
separately as well as collectively (7 fold, P value = 0.0001)
compared to that (median DCt6S.D= 15.4961.25) of non-risk
CC genotype group (Figure 1C & D).
To reinforce the hypothesis that A+1188C change affects the
transcription levels of IL12B gene in vivo, we assayed if there was
any quantitative difference of transcripts represented by A and C
alleles in patients harboring heterozygote genotype. The test for
allelic-expression-imbalance (AEI) was carried out by amplification
and resequencing of 167 bp fragment that covered IL12+1188
from cDNAs and gDNAs of twenty eight individuals with AC
genotype. The peak heights representing A (green peak) and C
(blue peak) alleles from individual electropherograms of paired
samples were determined using PeakPicker software (Figure 4A).
The average A to C peak height ratio ranged from 0.42–1.05 and
0.82–1.07 (Figure 4B) in cDNA and gDNA respectively and the
comparison of these ratios was statistically significant (P val-
ue = 0.0048) estimated by nonparametric Sign test (Figure 4C).
The allele specific expression of IL12B in the peripheral blood
mononuclear cells (PBMCs) of malaria patients by 39UTR
polymorphism may be attributed to (i) differential transcript
stability, (ii) influence of microRNAs and (iii) conformational
change in RNA secondary structure.
IL12B+1188 allele-based mRNA stability assay: Inhibition
of transcription by actinomycin-D
In order to directly assay differences in mRNA stability between
IL12B 39UTR alleles, we determined mRNA levels in cells
transfected with plasmids in which 1047 bp region from IL12B
39UTR representing A or C (+1188) allele was cloned under
Renilla luciferase gene with SV40 constitutive promoter in the
vector pSiCHECK2 (Figure 5A). Twenty four hours post-
transfection, HepG2 cells were treated with actinomycin-D
(5 mg/ml) to suppress de novo transcription. Figure 4D represents
the dose response and time kinetics of actinomycin-D treatment
that enabled us to select for the optimum treatment conditions for
the drug. mRNA levels at 0 and 24 hours after the drug treatment
were quantified by real-time PCR using IL12B and GAPDH (as
endogenous control) specific primers. As shown in Figure 4E, the
IL12B mRNA levels had declined 3.2 and 1.6 folds respectively for
A (DCt at 0 hr = 3.5760.39 vs DCt at 24 hr = 5.2360.17) and C (DCt
at 0 hr = 3.4460.68 vs DCt at 24 hr = 4.1260.47) alleles compared to
their respective starting levels suggesting that A+1188C polymor-
phism differentially influenced IL12B mRNA stability.
Influence of microRNA regulators targeting IL12B 39UTR
To identify the putative microRNA binding sites in the 39UTR
of IL12B gene we employed a consensus approach by using
different miRNA target prediction softwares, viz. TargetScan,
MiRanda, MicroCosm, miRBase and RegRNA. A comprehensive
microRNA map of IL12B 39UTR predicted consensusly by at least
three different databases was presented in the Figure 5B. Four
candidate microRNAs from this list were selected for cell based
reporter gene assay as they were located in the closest proximity of
the polymorphic site (hsa-miR545 and hsa-miR-1284) and
conserved among species (hsa-miR23a and hsa-miR-23b). Their
respective seed sequences were shown in Figure 5C.
The precursor microRNA (pre-miR) sequences for each of these
four regulatory RNAs were extracted from GeneCard database
followed by amplification of a region encompassing 100 bp
upstream and downstream of the mature miRNA and cloning in
appropriate orientation into pRNAU6.1 vector. To verify whether
A+1188C SNP alters the binding and regulation incurred by the
above candidate microRNAs, we transfected each of these pre-
miR constructs in HepG2 cells along with the 1047 bp segment of
IL12B 39UTR containing either +1188A or +1188C variant cloned
into the 39UTR of luciferase gene in pSiCHECK2 plasmid.
Reporter plasmid co-transfected with empty miR-pRNAU6.1
vector served as the control and luciferase expression was
measured 48 hours post-transfection. All the experiments were
done in triplicate and repeated thrice and the change of luciferase
gene expression was denoted as normalized RLU (in percentage)
relative to the control. Co-transfection of hsa-miR-23a
(33.33%60.08, P value = 0.0043) and hsa-miR-23b
(22.22%60.04, P value = 0.0179) with pSiCHECK2-IL12B-
+1188A resulted in significant reduction in Renilla luciferase
expression (Figure 5D). Similar reduction of reporter gene
expression was observed when hsa-miR-23a (36.6%61.15, P
value = 0.0001) and hsa-miR-23b (20%62.06, P value = 0.003)
were transfected with pSiCHECK2-IL12B-+1188C (Figure 5E).
On the other hand, luciferase activity from neither pSiCHECK2-
IL12B-+1188A nor pSiCHECK2-IL12B-+1188C construct was
altered by hsa-miR-545 (A=4.35%60.4 and C=4.08%60.5)
and hsa-miR-1284 (A= 12.61%60.5 and C=4.1%60.6). Similar
trend of hsa-miR-23a and hsa-miR-23b mediated reduction of
luciferase activity from pSiCHECK2-IL12B-+1188 A & C
constructs were observed in HCT116 and U937 cells (data not
shown). Taken together, our results suggest that hsa-miR-23a and
hsa-miR-23b bind to IL12B 39UTR, however, none of them exerts
any allele specific influence over the IL12B expression.
Allele dependent conformational changes in RNA
secondary structure
There is increasing evidence that cis-regulatory RNA structural
elements within mRNAs mediate post-transcriptional gene regu-
lation by determining several aspects of the mRNA life cycle such
as stability, localization, and translational efficiency [67,68].
However, RNA structures are dynamic and evolved to adopt
multiple conformations forming an ensemble that may be best
described by a partition function defined as the probabilities of all
possible base pairings [69]. To predict if A+1188C polymorphism
provides any localized effect on the structural ensemble of IL12B
mRNA, we reconstructed foldings of 101 nucleotide RNA
sequences using four different bases (A, G, U and C) in the
central 51st position, keeping 50 nucleotides upstream and
downstream sequences with respect to +1188 site identical. The
partition function matrices computed for all four sequences using
SNPfold were represented as dot-plots where probability of each
base-pairing was denoted by a dot (Figure 6A to D). The pairwise
Pearson correlation coefficients of A to G, A to U and A to C were
0.998, 0.925 and 0.751 respectively indicating a significant (P
value = 0.013) modulation of overall structural assembly for A to C
change (Figure 6A to D).
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Mountain plots were generated for 101 nucleotide sequences
harboring A and C alleles (Figure 6E & F). A mountain plot
represents the secondary structure in a plot of height versus
position where the height m(k) is given by the number of base pairs
enclosing the base at position k. The red, green and blue curves
represent minimum free energy structure, thermodynamic ensem-
ble of RNA structures and the centroid structure respectively. The
overlap between the red and green lines in Figure 6E suggested
that structure produced by A allele was closer to that predicted by
MFE. The blue plateau in Figure 6F indicated the central
tendency of the C allele to remain in open conformation.
Deviation from the base line in the position versus entropy graph
of C allele shown in lower panel signified a higher randomness and
positional entropy in the local structures involving C allele
(Figure 6F). This also gave rise to a higher Ensemble Diversity
(ED) in the structural constellation generated by C at position 51
(EDA= 20.73 vs EDC=34.06). Taken together, the in silico
modeling of RNA secondary structure indicated an overall
conformational dissimilarity in the base-pairing probabilities of
the RNA thermodynamic ensemble marked by A and C alleles
which could result in an alternative cis-regulatory functions
mediated by IL12B 39UTR polymorphism.
Discussion
Malaria epidemiology studies have shown that, within human
populations, a high degree of variation exists between individuals
with respect to malaria susceptibility phenotypes, including
parasite load, disease incidence, severity, and the magnitude and
type of immune responses to malaria antigens [70]. Immune
response to malaria has been an object of extensive investigation
aiming at understanding the genetic regulation since an inappro-
priate immune response leads to uncontrolled parasite replication
and is detrimental to host fitness [71]. A large body of the
literature has demonstrated that protection against severe P.
falciparum malaria is provided by distinct genetic traits, while
relatively less is known about the mild events which clearly
constitute a substantial fraction of global socioeconomic burden of
malaria [72–74]. To understand the role of host genetics in the
susceptibility and clinical course of mild malaria, we in this study,
primarily rely on reconstruction of genetic interactions among toll-
like receptors (TLRs) and pro-inflammatory cytokine genes
together with an indepth functional appraisal of determinants
associated with variation in blood parasite level.
Over the past several years, genetic epidemiology studies
technologically have progressed from investigating few candidate
markers to interrogating thousands of variants in genome-wide
Figure 4. IL12B 39UTR based AEI analysis. (A) Representative electropherograms showing the peak heights of the sequence encompassing
IL12B+1188 locus in gDNA (lower panel) and cDNA (upper panel) extracted from the heterozygous (AC) patients’ PBMC samples. The arrowhead
indicates the +1188 site. Here A and C alleles are represented as green and blue peaks respectively. Difference in peak heights in sequences between
cDNA and gDNA was evident. (B) Bar graph displays the A/C peak height ratios in individual heterozygous samples (N = 22). The dotted line indicates
the baseline where the A/C ratio is one. (C) The departure of A/C peak height ratios from baseline in gDNA and cDNA were shown in the form of bar
diagram. Each bar represents the mean height and corresponding standard deviation. The statistical difference of this distribution was measured by
Sign test. P value has been indicated. (D) Dose-response and time-course assay of actinomycin-D treatment by real time PCR. (E) HepG2 cells
(16105cells/ml) were treated with the optimum dose of actinomycin-D (5 mg/ml), harvested after 0 and 24 hours after treatment and IL12B mRNA
levels were measured and corrected for GAPDH mRNA for both the wild-type and variant pSiCHECK2-39UTR constructs. Statistical significance was
measured by t-test. (*) indicates the P values to be statistically significant.
doi:10.1371/journal.pone.0046441.g004
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association studies (GWAS) while the data analysis mostly focuses
on detecting single SNP effects [75,76]. Looking beyond the
boundary of additive inheritance of SNPs using marker by marker
approach may offer a better exercise to identify genetic
determinants and biological mechanisms involved in disease
etiology. Keeping this in mind, we have used MDR to reduce
the dimensionality of the multilocus genetic data pertaining to
immune response components to identify combinations of
polymorphisms associated with the risk of high parasite load.
MDR introduced by Ritchie, et al. is a computational strategy to
detect and characterize gene-gene interactions that may be
associated with disease susceptibility [41]. So far, MDR and its
extensions such as GMDR, FAM-MDR, MDR-PDT, EMDR
[77–80] have identified many interacting genetic variants under-
lying a wide variety of complex human diseases such as
Alzheimer’s disease, asthma, atrial fibrillation, autism, bladder
cancer, hypertension, nicotine dependency, prostate cancer,
schizophrenia, sporadic breast cancer and type II diabetes [81–
89]. In our study single SNP and multifactor dimensionality
reduction analyses together identified three genetic loci which
served as important factors in controlling blood parasitemia in
mild malaria. These loci include TLR4Thr399Ile, TNF-1031 and
IL12B+1188. Two additional loci viz. LTA80 and TLR9P545P
appear in combination with TLR4Thr399Ile and IL12B+1188
suggesting that the formers fail to show statistically significant
association in independent analyses because of their minor effects
Figure 5. IL12B mRNA-microRNA interaction assay. (A) Schematic representation of reporter gene constructs for IL12B 39UTR A and C alleles
used for transfection assays. (B) Entire 39UTR region was mapped for putative microRNA binding sites. The highlighted, boldfaced and underlined
segments within IL12B sequence were the seed sequences for the miRNAs. (C) Schematic representation of the score and seed position of four
miRNAs on target IL12B. (D & E) Normalized luciferase relative light units (RLU) in HepG2 cells were measured for IL12B+1188 A and C allele containing
pSiCHECK2 constructs with (+) and without (2) the effect of miRNAs. Co-transfection of the empty pRNAU6.1 (+) vector with pSiCHECK2-IL12B+1188
construct was set as 100% and reductions in luciferase expression in presence of four miRNAs were measured in relation to this. hsa-miR-23a and hsa-
miR-23b resulted in significant reduction in luciferase activities for both pSiCHECK2-IL12B+1188A and pSiCHECK2-IL12B+1188C constructs. Statistical
significance was measured with t-test. (*) indicates the P values and percentage reduction to be statistically significant.
doi:10.1371/journal.pone.0046441.g005
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on trait variation (Table 3) [90]. Notably, the minor allele
frequencies of both LTA80 and TLR9P545P were approximately
40% in our samples [21]. The presence of IL12B+1188 in five of
six models and elevation of odds ratio of TLR4Thr399Ile, TNF-
1031 and LTA80 in combination with IL12B+1188 are suggestive
of a pivotal genetic influence of IL12B on malaria phenotype. This
is supported by the fact that different malaria phenotypes such as
hyperparasitemia, severe malarial anemia or cerebral malaria are
often found to be associated with IL12B gene [34,91–94] while the
genetic alliance between parasitemia with LTA is seldom
unequivocal [95–97]. A study conducted among 198 individuals
belonging to 34 families living in Burkina Faso using the pedigree-
based generalized multifactor dimensionality reduction approach,
identified statistical interactions among immune genes including
IL12B 39 untranslated region, IL12Bpro, LTA+80 for mild malaria,
maximum parasitemia or asymptomatic parasitemia [98] under-
scoring the usefulness of modeling gene-gene interaction in genetic
dissection of complex diseases (Table 3).
The association of high parasitemia with IL12B+1188 (Table 1)
and significantly low expression of the cytokine in individuals
harboring risk genotypes (Figure 1) indicate that the susceptible
individuals are deficient in controlling parasite replication due to
inadequate level of IL12B transcript in mild malaria patients.
Critical role of IL12B in malaria has been demonstrated by other
studies that show IL12 production is inversely associated with
disease severity in human malaria [94,99,100] and the molecule is
extremely effective in correcting malarial anemia in murine model
[101,102]. Reduced expression of IL12B and LTA under TLR4
risk genotype background may be attributed to altered TLR4
signaling (Figure 2). To the best of our knowledge, this is the first
report that provides functional validation of statistical epistatic
models demonstrating in vivo suppression of cytokine gene
expression due to genetic deficiency of TLR4 signaling. The
attenuated TLR4 signaling by the variant receptors may be
ascribed to altered distribution of electrostatic surface potential as
shown by homology modeling in our previous study [21].
However, it should be borne in mind, a comprehensive profiling
of transcriptome and network analyses are necessary to identify
additional genetic partners involved in the pathway.
Pinpointing phenotypically causal variants from a large fraction
of SNPs that show statistical association to diseases remains a
major challenge. Only a handful of disease-associated variants
occur at non-synonymous (nsSNPs) sites while a majority are
located on the non-coding genomic regions (ncSNPs) adjacent to
protein coding genes suggesting that the latter may be involved in
transcriptional regulation. Global expression quantitative trait loci
(eQTL) analyses in yeast, mice, and humans have detected
significant levels of cis and trans-eQTL that simultaneously regulate
a large fraction of the transcriptome [103–108]. We previously
reported that the polymorphism located at TNF-1031 displayed
significant association with peripheral parasite load [21]. Here we
showed that any variation from the TNF-a wild-type haplotype
resulted in reduced promoter efficiency and the maximal
reduction was observed for the haplotype that was altered at
21031 locus. The dysfunctioning of TNF-a promoter due to
21031 polymorphism may be attributed to allelic differences in
Figure 6. IL12B 39UTR polymorphism based RNA ensemble structures. (A–D) display the SNPfold derived partition function heat maps
generated for 101 nucleotide sequences harboring A (risk), G, U and C (non-risk) alleles respectively at the 51st position. The partition function matrix
illustrates the base-pairing probabilities represented by dots. We estimated the pairwise Pearson correlation coefficient with respect to wild-type A
allele and P values to quantify the overall modulation in the RNA structural ensemble caused by a mutation. (*) indicates the P value to be statistically
significant. (E & F) show the mountain plot diagrams for IL12+1188A and C allele for 101 bases using RNAfold. The upper panel demonstrates the
height vs position graph in which the red, green and blue lines depict the minimum free energy structure, the partition function of all possible RNA
secondary structures and ensemble centroid structure respectively. The lower panel represents the entropy vs position profile and arrowhead
denotes the 51st position, the location of A+1188C. (G & H) shows allele specific minimum free energy (MFE) conformations generated from RNA
MFOLD. Numbers indicate the base position while the arrow directs the position of the polymorphic site.
doi:10.1371/journal.pone.0046441.g006
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binding of transcription factors (TFs). A number of transcription
factor binding sites (TFBSs) were abolished in presence of the
variant allele (C) which assumed a sterically inaccessible locked-in
conformation as depicted in the bioinformatic outputs (Figure 3D–
F). Chromatin immunoprecipitation or electrophoretic mobility
shift assays (EMSA) are necessary to validate in-silico prediction of
altered binding affinity between putative TFs and promoter SNP.
Reduction of transcriptional activity due to single nucleotide
variation in TNF-a promoter has been reported for the polymor-
phisms located at 2863 [109], 2376 [110] and 2238 [111].
Allelic-expression-imbalance (AEI) phenomenon which serves
as an integrative quantitative measure of any and all cis-acting
regulatory variants [112] is highly context-specific [113] and
widespread not only in humans and mice but in most organisms
[114–120]. It can affect the transcriptome by altering stability
[121], processing efficiency [122], isoform expression of mRNAs
[123,124] and inducing epigenetic changes [125,126]. The
unequal expression of IL12B between marker genotypes and
allelic imbalance detected in malaria patients’ PBMC samples
strongly suggest that IL12B+1188 polymorphism executes a cis-
regulatory function. To interpret the probable mechanisms of
IL12B+1188 mediated AEI, we have investigated allele specific
transcript stability, differential interaction of IL12B 39UTR with
candidate microRNAs and allele-dependent modulation of RNA
sub-optimal structures. The remarkable modulation of local RNA
secondary structures due to A to C transversion observed in this
study may affect the transcript stability directly or through the
association of RNA-binding proteins (RBPs) indirectly [69]. Many
RNA binding proteins have both sequence-specificity and RNA-
secondary structure binding preferences and are known to co-
regulate functionally related transcripts [127]. From SNP-targeted
studies, it has been estimated that 20% of the measured transcripts
show 1.5 fold differences between alleles while 30% show 1.2 fold
differences [118,128]. However, it is still obscure how small allelic
imbalance may cause a phenotype and how accurate the
bioinformatic predictions are with actual experimental evidences.
Recent studies have also shown that 39UTRs contain recogni-
tion motifs for microRNAs (miRNAs) which play important gene-
regulatory roles by pairing to their target mRNAs to direct
posttranscriptional repression. The most accurate predictors of
miRNA target sites relies on conserved matches to the ,7 bp seed
region near the 59end of the microRNA and also on the
accessibility of target sites. The four candidate microRNAs (hsa-
miR-545, hsa-miR-1284, hsa-miR-23a and hsa-miR-23b) predict-
ed in common from multiple databases target IL12B 39UTR
sequence located proximally to A+1188C. Our data showed hsa-
miR23a and hsa-miR-23b interacts with IL12B 39UTR to repress
gene expression without any allelic bias. This may be attributed to
our reductionist approach to candidate microRNA prediction and
limited ability of the current prediction algorithms that calculate
target efficacy based on interactions between the mRNA with itself
and the mRNA with a miRNA. This is of particular importance
because mRNA-miRNA interaction occurs in a complex cellular
environment in which mRNAs and miRNAs are likely to be
bound by cellular RNA-binding proteins, which are currently
impossible to account for in silico. Our findings exemplify that
diversity of posttranscriptional gene regulation may extend beyond
microRNAs and underscores the importance of characterization of
structural cis-regulatory elements and their interaction partners in
the context of mRNA stability. Recently, there has been renewed
interest in identifying the effects of disease-associated noncoding
SNPs on changes in RNA structure [129,130] which may regulate
gene expression at virtually every possible stage ranging from local
chromatin remodeling to mRNA translation [131–133]. Taken
together, our findings convincingly demonstrated inadequate gene
expression of pro-inflammatory cytokines, namely IL12B and
TNF-a attributable to cis-regulatory polymorphisms together with
loss of efficacious TLR4 mediated signaling due to nsSNP
contribute to uncontrolled parasite growth in P.falciparum malaria
in an epistatic manner. In the study of genetics of complex
diseases, to determine which of the multitude of variants carried by
an individual are responsible for a given phenotype remains a
massive task. Our study emphasizes the need to evaluate gene-
gene interaction and biological credibility of hundreds of common
non-coding variants with low effect size as powerful complemen-
tary research strategies to illuminate the genetic architecture of
common diseases.
Supporting Information
Table S1 Oligonucleotide sequences.
(DOC)
Acknowledgments
We are grateful to all study participants for their cooperation. We thank
CAS (UGC), DST-FIST, and IPLS (DBT) for providing some of the
instrument facilities at the Department of Biochemistry, University of
Calcutta. We are thankful to Ms. Sanmitra Basu and Ms. Rebecca
Chowdhury of Department of Biochemistry, University of Calcutta for
critical review of the manuscript.
Author Contributions
Conceived and designed the experiments: SS MB. Performed the
experiments: MB TD AG SM. Analyzed the data: MB SS. Contributed
reagents/materials/analysis tools: SR AKM SDK. Wrote the paper: SS
MB. Guided the MDR analysis: IM. Provided cell line and vectors: SB.
References
1. World Health Organization (2011) World Malaria Report. GenevaSwitzer-
Switzerland: World Health Organization.
2. Stevenson MM, Tam MF (1993) Differential induction of helper T cell subsets
during blood-stage Plasmodium chabaudi AS infection in resistant and
susceptible mice. Clin Exp Immunol 92: 77–83.
3. Taylor-Robinson AW, Phillips RS (1994) B cells are required for the switch
from Th1- to Th2-regulated immune responses to Plasmodium chabaudi
chabaudi infection. Infect Immun 62: 2490–2498.
4. Ing R, Stevenson MM (2009) Dendritic cell and NK cell reciprocal cross talk
promotes gamma interferon-dependent immunity to blood-stage Plasmodium
chabaudi AS infection in mice. Infect Immun 77: 770–782.
5. Metcalf CJ, Graham AL, Huijben S, Barclay VC, Long GH, et al. (2011)
Partitioning regulatory mechanisms of within-host malaria dynamics using the
effective propagation number. Science 333: 984–988.
6. Francis SE, Sullivan DJ Jr, Goldberg DE (1997) Hemoglobin metabolism in the
malaria parasite Plasmodium falciparum. Annu Rev Microbiol 51: 97–123.
7. Franklin BS, Parroche P, Ataide MA, Lauw F, Ropert C, et al. (2009) Malaria
primes the innate immune response due to interferon-gamma induced
enhancement of toll-like receptor expression and function. Proc Natl Acad
Sci U S A 106: 5789–5794.
8. Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, et al. (2006) Innate
immune responses to human malaria: heterogeneous cytokine responses to
blood-stage Plasmodium falciparum correlate with parasitological and clinical
outcomes. J Immunol 177: 5736–5745.
9. Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343: 338–
344.
10. Stevenson MM, Riley EM (2004) Innate immunity to malaria. Nat Rev
Immunol 4: 169–180.
11. Abel L (1999) Genetic epidemiology in the study of susceptibility/resistance to
malaria in the human population. Bull Soc Pathol Exot 92: 256–260.
12. Hill AV (1996) Genetic susceptibility to malaria and other infectious diseases:
from the MHC to the whole genome. Parasitology 112 Suppl: S75–84.
13. Hill AV (1999) The immunogenetics of resistance to malaria. Proc Assoc Am
Physicians 111: 272–277.
14. Kwiatkowski D (1999) The molecular genetic approach to malarial
pathogenesis and immunity. Parassitologia 41: 233–240.
Polymorphisms Controlling P. falciparum Parasitemia
PLOS ONE | www.plosone.org 15 October 2012 | Volume 7 | Issue 10 | e46441
15. Ndiaye R, Sakuntabhai A, Casademont I, Rogier C, Tall A, et al. (2005)
Genetic study of ICAM1 in clinical malaria in Senegal. Tissue Antigens 65:
474–480.
16. Diakite M, Clark TG, Auburn S, Campino S, Fry AE, et al. (2009) A genetic
association study in the Gambia using tagging polymorphisms in the major
histocompatibility complex class III region implicates a HLA-B associated
transcript 2 polymorphism in severe malaria susceptibility. Hum Genet 125:
105–109.
17. Sikora M, Ferrer-Admetlla A, Laayouni H, Menendez C, Mayor A, et al.
(2009) A variant in the gene FUT9 is associated with susceptibility to placental
malaria infection. Hum Mol Genet 18: 3136–3144.
18. Sikora M, Laayouni H, Menendez C, Mayor A, Bardaji A, et al. (2011) A
targeted association study of immunity genes and networks suggests novel
associations with placental malaria infection. PLoS One 6: e24996.
19. Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, et al. (2011)
Genetic polymorphisms linked to susceptibility to malaria. Malar J 10: 271.
20. Timmann C, Evans JA, Konig IR, Kleensang A, Ruschendorf F, et al. (2007)
Genome-wide linkage analysis of malaria infection intensity and mild disease.
PLoS Genet 3: e48.
21. Basu M, Maji AK, Chakraborty A, Banerjee R, Mullick S, et al. (2010) Genetic
association of Toll-like-receptor 4 and tumor necrosis factor-alpha polymor-
phisms with Plasmodium falciparum blood infection levels. Infect Genet Evol
10: 686–696.
22. Stevenson MM, Su Z, Sam H, Mohan K (2001) Modulation of host responses
to blood-stage malaria by interleukin-12: from therapy to adjuvant activity.
Microbes Infect 3: 49–59.
23. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and
adaptive immunity. Nat Rev Immunol 3: 133–146.
24. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, et al. (2000) Genetic
polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun
1: 219–224.
25. Navikas V, Link H (1996) Review: cytokines and the pathogenesis of multiple
sclerosis. J Neurosci Res 45: 322–333.
26. Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, et al. (2001)
Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory
IL12B allele. Nat Genet 27: 218–221.
27. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A
genome-wide association study identifies IL23R as an inflammatory bowel
disease gene. Science 314: 1461–1463.
28. Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, et al. (2008)
Polymorphisms of the IL12B and IL23R genes are associated with psoriasis.
J Invest Dermatol 128: 1653–1661.
29. Mangino M, Braund P, Singh R, Steeds R, Stevens S, et al. (2008) Association
analysis of IL-12B and IL-23R polymorphisms in myocardial infarction. J Mol
Med (Berl) 86: 99–103.
30. Miteva LD, Manolova IM, Ivanova MG, Rashkov RK, Stoilov RM, et al.
(2012) Functional genetic polymorphisms in interleukin-12B gene in association
with systemic lupus erythematosus. Rheumatol Int 32: 53–59.
31. Tso HW, Lau YL, Tam CM, Wong HS, Chiang AK (2004) Associations
between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese
population. J Infect Dis 190: 913–919.
32. Zhang L, Prather D, Vanden Eng J, Crawford S, Kariuki S, et al. (2010)
Polymorphisms in genes of interleukin 12 and its receptors and their association
with protection against severe malarial anaemia in children in western Kenya.
Malar J 9: 87.
33. Keller CC, Yamo O, Ouma C, Ong’echa JM, Ounah D, et al. (2006)
Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-
12p40) transcripts and circulating IL-12p70 through an IL-10-dependent
mechanism: in vivo and in vitro findings in severe malarial anemia. Infect
Immun 74: 5249–5260.
34. Morahan G, Boutlis CS, Huang D, Pain A, Saunders JR, et al. (2002) A
promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is
associated with mortality from cerebral malaria and with reduced nitric oxide
production. Genes Immun 3: 414–418.
35. Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, et al. (2011)
Trans-eQTLs reveal that independent genetic variants associated with a
complex phenotype converge on intermediate genes, with a major role for the
HLA. PLoS Genet 7: e1002197.
36. Frazer KA, Murray SS, Schork NJ, Topol EJ (2009) Human genetic variation
and its contribution to complex traits. Nat Rev Genet 10: 241–251.
37. Jais PH (2005) How frequent is altered gene expression among susceptibility
genes to human complex disorders? Genet Med 7: 83–96.
38. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M (2009) Mapping
complex disease traits with global gene expression. Nat Rev Genet 10: 184–
194.
39. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, et al. (2010) Trait-
associated SNPs are more likely to be eQTLs: annotation to enhance discovery
from GWAS. PLoS Genet 6: e1000888.
40. World Health Organization (2006) Guidelines for the treatment of malaria.
GenevaSwitzerland: World Health Organization.
41. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, et al. (2001)
Multifactor-dimensionality reduction reveals high-order interactions among
estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:
138–147.
42. Ritchie MD, Hahn LW, Moore JH (2003) Power of multifactor dimensionality
reduction for detecting gene-gene interactions in the presence of genotyping
error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol
24: 150–157.
43. Moore JH (2004) Computational analysis of gene-gene interactions using
multifactor dimensionality reduction. Expert Rev Mol Diagn 4: 795–803.
44. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, et al. (2006) A flexible
computational framework for detecting, characterizing, and interpreting
statistical patterns of epistasis in genetic studies of human disease susceptibility.
J Theor Biol 241: 252–261.
45. Moore JH, Williams SM (2009) Epistasis and its implications for personal
genetics. Am J Hum Genet 85: 309–320.
46. Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction
software for detecting gene-gene and gene-environment interactions. Bioinfor-
matics 19: 376–382.
47. Ririe KM, Rasmussen RP, Wittwer CT (1997) Product differentiation by
analysis of DNA melting curves during the polymerase chain reaction. Anal
Biochem 245: 154–160.
48. Ge B, Gurd S, Gaudin T, Dore C, Lepage P, et al. (2005) Survey of allelic
expression using EST mining. Genome Res 15: 1584–1591.
49. Waksman SA, Woodruff HB (1940) Bacteriostatic and bacteriocidal substances
produced by soil actinomycetes. Proc Soc Exper Biol 45: 609–614.
50. Sobell HM (1985) Actinomycin and DNA transcription. Proc Natl Acad
Sci U S A 82: 5328–5331.
51. Berg JM, Tymoczko JL, Stryer L (2002) Biochemistry. New York: W H
Freeman.
52. Tripathi G (2010) Cellular and Biochemical Science. New Delhi: I. K.
International Pvt Ltd. 567 p.
53. Zuker M (1989) Computer prediction of RNA structure. Methods Enzymol
180: 262–288.
54. SantaLucia J Jr (1998) A unified view of polymer, dumbbell, and
oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad
Sci U S A 95: 1460–1465.
55. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization
prediction. Nucleic Acids Res 31: 3406–3415.
56. Tsunoda T, Takagi T (1999) Estimating transcription factor bindability on
DNA. Bioinformatics 15: 622–630.
57. Betts L, Spremulli LL (1994) Analysis of the role of the Shine-Dalgarno
sequence and mRNA secondary structure on the efficiency of translational
initiation in the Euglena gracilis chloroplast atpH mRNA. J Biol Chem 269:
26456–26463.
58. Bindewald E, Shapiro BA (2006) RNA secondary structure prediction from
sequence alignments using a network of k-nearest neighbor classifiers. RNA 12:
342–352.
59. Hofacker IL, Stadler PF (2006) Memory efficient folding algorithms for circular
RNA secondary structures. Bioinformatics 22: 1172–1176.
60. Mathews DH, Sabina J, Zuker M, Turner DH (1999) Expanded sequence
dependence of thermodynamic parameters improves prediction of RNA
secondary structure. J Mol Biol 288: 911–940.
61. Xia T, SantaLucia J Jr, Burkard ME, Kierzek R, Schroeder SJ, et al. (1998)
Thermodynamic parameters for an expanded nearest-neighbor model for
formation of RNA duplexes with Watson-Crick base pairs. Biochemistry 37:
14719–14735.
62. Ding Y, Chan CY, Lawrence CE (2005) RNA secondary structure prediction
by centroids in a Boltzmann weighted ensemble. RNA 11: 1157–1166.
63. Ding Y, Chan CY, Lawrence CE (2006) Clustering of RNA secondary
structures with application to messenger RNAs. J Mol Biol 359: 554–571.
64. Schuetze N, Schoeneberger S, Mueller U, Freudenberg MA, Alber G, et al.
(2005) IL-12 family members: differential kinetics of their TLR4-mediated
induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-
derived macrophages. Int Immunol 17: 649–659.
65. May L, van Bodegom D, Frolich M, van Lieshout L, Slagboom PE, et al. (2010)
Polymorphisms in TLR4 and TLR2 genes, cytokine production and survival in
rural Ghana. Eur J Hum Genet 18: 490–495.
66. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal structure of the
TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:
906–917.
67. Namy O, Rousset JP, Napthine S, Brierley I (2004) Reprogrammed genetic
decoding in cellular gene expression. Mol Cell 13: 157–168.
68. Garneau NL, Wilusz J, Wilusz CJ (2007) The highways and byways of mRNA
decay. Nat Rev Mol Cell Biol 8: 113–126.
69. Halvorsen M, Martin JS, Broadaway S, Laederach A (2010) Disease-associated
mutations that alter the RNA structural ensemble. PLoS Genet 6: e1001074.
70. Verra F, Mangano VD, Modiano D (2009) Genetics of susceptibility to
Plasmodium falciparum: from classical malaria resistance genes towards
genome-wide association studies. Parasite Immunol 31: 234–253.
71. Graham AL, Allen JE, Read AF (2005) Evolutionary causes and consequences
of immunopathology. Ann Rev Ecol Evol Syst, 36: 373–398.
72. May J, Evans JA, Timmann C, Ehmen C, Busch W, et al. (2007) Hemoglobin
variants and disease manifestations in severe falciparum malaria. JAMA 297:
2220–2226.
73. Hill AV (2001) The genomics and genetics of human infectious disease
susceptibility. Annu Rev Genomics Hum Genet 2: 373–400.
Polymorphisms Controlling P. falciparum Parasitemia
PLOS ONE | www.plosone.org 16 October 2012 | Volume 7 | Issue 10 | e46441
74. Allison AC (2009) Genetic control of resistance to human malaria. Curr Opin
Immunol 21: 499–505.
75. Mechanic LE, Chen HS, Amos CI, Chatterjee N, Cox NJ, et al. (2011) Next
generation analytic tools for large scale genetic epidemiology studies of complex
diseases. Genet Epidemiol.
76. Billings LK, Florez JC (2010) The genetics of type 2 diabetes: what have we
learned from GWAS? Ann N Y Acad Sci 1212: 59–77.
77. Lou XY, Chen GB, Yan L, Ma JZ, Mangold JE, et al. (2008) A combinatorial
approach to detecting gene-gene and gene-environment interactions in family
studies. Am J Hum Genet 83: 457–467.
78. Cattaert T, Urrea V, Naj AC, De Lobel L, De Wit V, et al. (2010) FAM-MDR:
a flexible family-based multifactor dimensionality reduction technique to detect
epistasis using related individuals. PLoS One 5: e10304.
79. Mei H, Cuccaro ML, Martin ER (2007) Multifactor dimensionality reduction-
phenomics: a novel method to capture genetic heterogeneity with use of
phenotypic variables. Am J Hum Genet 81: 1251–1261.
80. Mei H, Ma D, Ashley-Koch A, Martin ER (2005) Extension of multifactor
dimensionality reduction for identifying multilocus effects in the GAW14
simulated data. BMC Genet 6 Suppl 1: S145.
81. Liang X, Slifer M, Martin ER, Schnetz-Boutaud N, Bartlett J, et al. (2009)
Genomic convergence to identify candidate genes for Alzheimer disease on
chromosome 10. Hum Mutat 30: 463–471.
82. Chan IH, Tang NL, Leung TF, Huang W, Lam YY, et al. (2008) Study of
gene-gene interactions for endophenotypic quantitative traits in Chinese
asthmatic children. Allergy 63: 1031–1039.
83. Asselbergs FW, Moore JH, van den Berg MP, Rimm EB, de Boer RA, et al.
(2006) A role for CETP TaqIB polymorphism in determining susceptibility to
atrial fibrillation: a nested case control study. BMC Med Genet 7: 39.
84. Ma DQ, Whitehead PL, Menold MM, Martin ER, Ashley-Koch AE, et al.
(2005) Identification of significant association and gene-gene interaction of
GABA receptor subunit genes in autism. Am J Hum Genet 77: 377–388.
85. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, et al. (2006)
Concordance of multiple analytical approaches demonstrates a complex
relationship between DNA repair gene SNPs, smoking and bladder cancer
susceptibility. Carcinogenesis 27: 1030–1037.
86. Li MD, Mangold JE, Seneviratne C, Chen GB, Ma JZ, et al. (2009) Association
and interaction analyses of GABBR1 and GABBR2 with nicotine dependence
in European- and African-American populations. PLoS One 4: e7055.
87. Beuten J, Gelfond J, Franke J, Weldon K, Crandall A, et al. (2009) Single and
multigenic analysis of the association between variants in 12 steroid hormone
metabolism genes and risk of prostate cancer. Cancer Epidemiol Biomarkers
Prev 18: 1869–1880.
88. Qin S, Zhao X, Pan Y, Liu J, Feng G, et al. (2005) An association study of the
N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit
gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur J Hum
Genet 13: 807–814.
89. Neuman R, Wasson J, Atzmon G, Wainstein J, Yerushalmi Y, et al. (2010)
Gene-gene interactions lead to higher risk for development of type 2 diabetes in
an Ashkenazi Jewish population. PLoS One 5: e9903.
90. Park JH, Gail MH, Weinberg CR, Carroll RJ, Chung CC, et al. (2011)
Distribution of allele frequencies and effect sizes and their interrelationships for
common genetic susceptibility variants. Proc Natl Acad Sci U S A 108: 18026–
18031.
91. Marquet S, Doumbo O, Cabantous S, Poudiougou B, Argiro L, et al. (2008) A
functional promoter variant in IL12B predisposes to cerebral malaria. Hum
Mol Genet 17: 2190–2195.
92. Ong’echa JM, Raballah EO, Kempaiah PM, Anyona SB, Were T, et al. (2011)
Polymorphic variability in the 39 untranslated region (UTR) of IL12B is
associated with susceptibility to severe anaemia in Kenyan children with acute
Plasmodium falciparum malaria. BMC Genet 12: 69.
93. Phawong C, Ouma C, Tangteerawatana P, Thongshoob J, Were T, et al.
(2010) Haplotypes of IL12B promoter polymorphisms condition susceptibility
to severe malaria and functional changes in cytokine levels in Thai adults.
Immunogenetics 62: 345–356.
94. Boutlis CS, Lagog M, Chaisavaneeyakorn S, Misukonis MA, Bockarie MJ, et
al. (2003) Plasma interleukin-12 in malaria-tolerant papua new guineans:
inverse correlation with Plasmodium falciparum parasitemia and peripheral
blood mononuclear cell nitric oxide synthase activity. Infect Immun 71: 6354–
6357.
95. Barbier M, Delahaye NF, Fumoux F, Rihet P (2008) Family-based association
of a low producing lymphotoxin-alpha allele with reduced Plasmodium
falciparum parasitemia. Microbes Infect 10: 673–679.
96. Clark TG, Diakite M, Auburn S, Campino S, Fry AE, et al. (2009) Tumor
necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in
African populations. J Infect Dis 199: 569–575.
97. Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, et al.
(2010) A study of the TNF/LTA/LTB locus and susceptibility to severe
malaria in highland papuan children and adults. Malar J 9: 302.
98. Atkinson A, Barbier M, Afridi S, Fumoux F, Rihet P (2011) Evidence for
epistasis between hemoglobin C and immune genes in human P. falciparum
malaria: a family study in Burkina Faso. Genes Immun 12: 481–489.
99. Perkins DJ, Weinberg JB, Kremsner PG (2000) Reduced interleukin-12 and
transforming growth factor-beta1 in severe childhood malaria: relationship of
cytokine balance with disease severity. J Infect Dis 182: 988–992.
100. Ong’echa JM, Remo AM, Kristoff J, Hittner JB, Were T, et al. (2008)
Increased circulating interleukin (IL)-23 in children with malarial anemia: in
vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10.
Clin Immunol 126: 211–221.
101. Stevenson MM, Su Z, Sam H, Mohan K (2001) Modulation of host responses
to blood-stage malaria by interleukin-12: from therapy to adjuvant activity.
Microbes Infect 3: 49–59.
102. Mohan K, Stevenson MM (1998) Interleukin-12 corrects severe anemia during
blood-stage Plasmodium chabaudi AS in susceptible A/J mice. Exp Hematol
26: 45–52.
103. Jansen RC, Nap JP (2001) Genetical genomics: the added value from
segregation. Trends Genet 17: 388–391.
104. Doerge RW (2002) Mapping and analysis of quantitative trait loci in
experimental populations. Nat Rev Genet 3: 43–52.
105. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, et al. (2003) Genetics of
gene expression surveyed in maize, mouse and man. Nature 422: 297–302.
106. Brem RB, Yvert G, Clinton R, Kruglyak L (2002) Genetic dissection of
transcriptional regulation in budding yeast. Science 296: 752–755.
107. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. (2004)
Genetic analysis of genome-wide variation in human gene expression. Nature
430: 743–747.
108. West MA, Kim K, Kliebenstein DJ, van Leeuwen H, Michelmore RW, et al.
(2007) Global eQTL mapping reveals the complex genetic architecture of
transcript-level variation in Arabidopsis. Genetics 175: 1441–1450.
109. Skoog T, van’t Hooft FM, Kallin B, Jovinge S, Boquist S, et al. (1999) A
common functional polymorphism (CRA substitution at position 2863) in the
promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene
associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8:
1443–1449.
110. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, et al. (1999) A
polymorphism that affects OCT-1 binding to the TNF promoter region is
associated with severe malaria. Nat Genet 22: 145–150.
111. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, et al. (2000) Different
transcriptional activity and in vitro TNF-alpha production in psoriasis patients
carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 114:
1180–1183.
112. Wang D, Sadee W (2006) Searching for polymorphisms that affect gene
expression and mRNA processing: example ABCB1 (MDR1). AAPS J 8: E515–
520.
113. Knight JC (2004) Allele-specific gene expression uncovered. Trends Genet 20:
113–116.
114. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW (2002) Allelic
variation in human gene expression. Science 297: 1143.
115. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, et al. (2003) Allelic variation in gene
expression is common in the human genome. Genome Res 13: 1855–1862.
116. Cowles CR, Hirschhorn JN, Altshuler D, Lander ES (2002) Detection of
regulatory variation in mouse genes. Nat Genet 32: 432–437.
117. Verlaan DJ, Ge B, Grundberg E, Hoberman R, Lam KC, et al. (2009)
Targeted screening of cis-regulatory variation in human haplotypes. Genome
Res 19: 118–127.
118. Ge B, Pokholok DK, Kwan T, Grundberg E, Morcos L, et al. (2009) Global
patterns of cis variation in human cells revealed by high-density allelic
expression analysis. Nat Genet 41: 1216–1222.
119. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, et al. (2009)
Common regulatory variation impacts gene expression in a cell type-dependent
manner. Science 325: 1246–1250.
120. Majewski J, Pastinen T (2011) The study of eQTL variations by RNA-seq: from
SNPs to phenotypes. Trends Genet 27: 72–79.
121. Carter AM, Sachchithananthan M, Stasinopoulos S, Maurer F, Medcalf RL
(2002) Prothrombin G20210A is a bifunctional gene polymorphism. Thromb
Haemost 87: 846–853.
122. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, et al. (2001)
Increased efficiency of mRNA 39 end formation: a new genetic mechanism
contributing to hereditary thrombophilia. Nat Genet 28: 389–392.
123. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, et
al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic
stroke. Nat Genet 35: 131–138.
124. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al. (2003) Association
of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
Nature 423: 506–511.
125. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, et al. (2003)
Variation in the HLA-G promoter region influences miscarriage rates.
Am J Hum Genet 72: 1425–1435.
126. Pastinen T, Hudson TJ (2004) Cis-acting regulatory variation in the human
genome. Science 306: 647–650.
127. Blencowe B, Brenner S, Hughes T, Morris Q (2009) Post-transcriptional gene
regulation: RNA-protein interactions, RNA processing, mRNA stability and
localization. Pac Symp Biocomput: 545–548
128. Zhang K, Li JB, Gao Y, Egli D, Xie B, et al. (2009) Digital RNA allelotyping
reveals tissue-specific and allele-specific gene expression in human. Nat
Methods 6: 613–618.
129. Martin JS, Halvorsen M, Davis-Neulander L, Ritz J, Gopinath C, et al. (2012)
Structural effects of linkage disequilibrium on the transcriptome. RNA 18: 77–
87.
Polymorphisms Controlling P. falciparum Parasitemia
PLOS ONE | www.plosone.org 17 October 2012 | Volume 7 | Issue 10 | e46441
130. Kiryu H, Asai K (2012) Rchange: algorithms for computing energy changes of
RNA secondary structures in response to base mutations. Bioinformatics 28:
1093–1101.
131. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, et al. (2007) Functional
demarcation of active and silent chromatin domains in human HOX loci by
noncoding RNAs. Cell 129: 1311–1323.
132. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT (2008) Polycomb proteins targeted
by a short repeat RNA to the mouse X chromosome. Science 322: 750–756.
133. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights
into functions. Nat Rev Genet 10: 155–159.
Polymorphisms Controlling P. falciparum Parasitemia
PLOS ONE | www.plosone.org 18 October 2012 | Volume 7 | Issue 10 | e46441
